Breztri Aerosphere 7.2 mcg

BREZTRI AEROSPHERE 7.2 MCG is a metered-dose aerosol containing glycopyrronium bromide, used for respiratory conditions. This inhalation medication helps manage symptoms like bronchospasms and improves breathing.

BREZTRI AEROSPHERE 7.2 MCG is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the airways, making it easier to breathe. This medication is often prescribed to individuals experiencing symptoms such as wheezing, shortness of breath, and coughing due to COPD. What is BREZTRI AEROSPHERE used for? It is designed to provide long-term relief and improve lung function in patients with this condition.

Common effects of BREZTRI AEROSPHERE 7.2 MCG may include dry mouth, throat irritation, and coughing immediately after inhalation. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

BREZTRI AEROSPHERE 7.2 MCG should be used with caution in patients with a history of hypersensitivity to glycopyrronium bromide or similar medications. It is important to follow the prescribed dosage and administration instructions carefully. Patients should avoid exposing the aerosol to extreme temperatures and store it in a cool, dry place.

BREZTRI AEROSPHERE 7.2 MCG may interact with other medications, including beta-blockers and certain antihistamines. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.